Lipid of the Month

Each month we highlight a lipid of scientific interest. The LIPID MAPS® Lipid of the Month Archive lists lipids highlighted from 2015 - present.

November 2026

Lipid of the month Myriocin

Over 50 years ago, a new anti-fungal compound was identified in the fungus Myriococcum albomyces and its chemical structure elucidated.1 The organism has since been reclassified as Melanocarpus albomyces but the name of the compound remains: myriocin.

Myriocin was rediscovered from a different fungal source twenty years later in a search for immunosuppressants, and found to be orders of magnitude more powerful than cyclosporin A in this activity.2

Myriocin is structurally similar to sphingosine and acts by inhibiting serine palmitoyltransferase (SPT).3 SPT is the enzyme which makes sphingosine and thus the initial step in ceramide biosynthesis. So potent an inhibitor is myriocin that it isn’t able to be used as a drug, but it is in common usage as a sphingolipid synthesis inhibitor in experimental contexts. Its structure led to the development of a related synthetic molecule called fingolimod, which seems not to inhibit SPT, but retains the immunosuppressant activity by binding sphingosine-1-phosphate receptors4. This suggests myriocin may have multiple targets, which is not surprising for a compound which mimics a molecule with multiple known functions and metabolic pathways.

Just recently, the biosynthesis pathway of myriocin has been proposed in a paper identifying the likely gene cluster in producing fungal strains.6 The work not only delineates the likely biosynthesis of myriocin, but finds that many more fungi may produce this, or similar bio-active sphingoid base mimetics.

References

  • Elucidation of structure and stereochemistry of myriocin. Novel antifungal antibiotic
    J Org Chem
    1973
    DOI 10.1021/jo00947a001
  • Fungal metabolites. Part 11. A potent immunosuppressive activity found in Isaria sinclairii metabolite
    J Antibiot
    1994
    DOI 10.7164/antibiotics.47.208
  • Serine Palmitoyltransferase Is the Primary Target of a Sphingosine-like Immunosuppressant, ISP-1/Myriocin
    Biochem Biophys Res Comm
    1995
    DOI 10.1006/bbrc.1995.1827
  • Discovery Of Fingolimod, The Sphingosine 1-Phosphate Receptor Modulator And Its Application For The Therapy Of Multiple Sclerosis
    Future Med Chem
    2012
    DOI 10.4155/fmc.12.25
  • Evolution, structure and function of the putative biosynthetic gene cluster of the fungal secondary metabolite myriocin, a potent inhibitory sphingolipid
    Commun Biol
    2026
    DOI 10.1038/s42003-026-10708-9

Lipid of the Month Archive

2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015